View in EDS

Innovative Nanocarriers of Sorafenib in the Optimisation of Therapeutic Outcome: Challenges and Applications in Breast Cancer.

Saved in:
Bibliographic Details
Title: Innovative Nanocarriers of Sorafenib in the Optimisation of Therapeutic Outcome: Challenges and Applications in Breast Cancer.
Authors: Chaurawal N; Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Bandarsindri, Ajmer, Rajasthan, 305817, India.; Institute of Cancer Therapeutics, Faculty of Life Sciences, University of Bradford, BD7 1DP, Bradford, UK., Estrada AR; Institute of Cancer Therapeutics, Faculty of Life Sciences, University of Bradford, BD7 1DP, Bradford, UK. g.ruizestrada@bradford.ac.uk., Pors K; Institute of Cancer Therapeutics, Faculty of Life Sciences, University of Bradford, BD7 1DP, Bradford, UK. K.Pors1@bradford.ac.uk., Raza K; Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Bandarsindri, Ajmer, Rajasthan, 305817, India. drkaisar@curaj.ac.in.; Institute of Cancer Therapeutics, Faculty of Life Sciences, University of Bradford, BD7 1DP, Bradford, UK. drkaisar@curaj.ac.in., Wahajuddin M; Institute of Cancer Therapeutics, Faculty of Life Sciences, University of Bradford, BD7 1DP, Bradford, UK. m.wahajuddin@bradford.ac.uk.
Source: AAPS PharmSciTech [AAPS PharmSciTech] 2026 Mar 19; Vol. 27 (3). Date of Electronic Publication: 2026 Mar 19.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 100960111 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-9932 (Electronic) Linking ISSN: 15309932 NLM ISO Abbreviation: AAPS PharmSciTech Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1530-9932
DOI:10.1208/s12249-026-03392-9